-
1
-
-
0014135334
-
Immunological studies of an atypical (myeloma) immunoglobulin
-
1:CAS:528:DyaF1cXitVGgtA%3D%3D 4168094
-
SG Johansson H Bennich 1967 Immunological studies of an atypical (myeloma) immunoglobulin Immunology 13 381 394 1:CAS:528:DyaF1cXitVGgtA%3D%3D 4168094
-
(1967)
Immunology
, vol.13
, pp. 381-394
-
-
Johansson, S.G.1
Bennich, H.2
-
2
-
-
0030906510
-
IgE lambda monoclonal gammopathy and amyloidosis
-
1:STN:280:DyaK2s3lvVKjtA%3D%3D 10.1159/000237490 9104800
-
JM Jako T Gesztesi I Kaszas 1997 IgE lambda monoclonal gammopathy and amyloidosis Int Arch Allergy Immunol 112 415 421 1:STN:280:DyaK2s3lvVKjtA%3D%3D 10.1159/000237490 9104800
-
(1997)
Int Arch Allergy Immunol
, vol.112
, pp. 415-421
-
-
Jako, J.M.1
Gesztesi, T.2
Kaszas, I.3
-
3
-
-
59149083550
-
Skin involvement in immunoglobulin e multiple myeloma
-
10.1200/JCO.2008.20.1491 19064952
-
JL Wozney F Ahmed MG Bayerl WC Ehmann G Talamo 2009 Skin involvement in immunoglobulin E multiple myeloma J Clin Oncol 27 637 638 10.1200/JCO.2008.20. 1491 19064952
-
(2009)
J Clin Oncol
, vol.27
, pp. 637-638
-
-
Wozney, J.L.1
Ahmed, F.2
Bayerl, M.G.3
Ehmann, W.C.4
Talamo, G.5
-
4
-
-
0032751739
-
IgE myeloma: A case presentation and a review of the literature
-
1:CAS:528:DC%2BD3cXkt1Sk 10.1080/00365519950185472 10612556
-
KJ Kairemo M Lindberg M Prytz 1999 IgE myeloma: a case presentation and a review of the literature Scand J Clin Lab Invest 59 451 456 1:CAS:528:DC%2BD3cXkt1Sk 10.1080/00365519950185472 10612556
-
(1999)
Scand J Clin Lab Invest
, vol.59
, pp. 451-456
-
-
Kairemo, K.J.1
Lindberg, M.2
Prytz, M.3
-
5
-
-
33847616009
-
Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma
-
DOI 10.1111/j.1600-0609.2007.00825.x
-
MJ Hayes JL Carey JC Krauss DL Hedstrom RL Gulbranson DF Keren 2007 Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma Eur J Haematol 78 353 357 1:CAS:528:DC%2BD2sXkvFegsr0%3D 10.1111/j.1600-0609.2007.00825.x 17378894 (Pubitemid 46365088)
-
(2007)
European Journal of Haematology
, vol.78
, Issue.4
, pp. 353-357
-
-
Hayes, M.J.1
Carey, J.L.2
Krauss, J.C.3
Hedstrom, D.L.4
Gulbranson, R.L.5
Keren, D.F.6
-
6
-
-
0037298929
-
A case of IgE multiple myeloma
-
1:CAS:528:DC%2BD3sXivVWlurc%3D 10.1080/0031302021000062424 12701695
-
L Lloyd SL Klingberg M Kende JF Howell AE Clague 2003 A case of IgE multiple myeloma Pathology 35 87 89 1:CAS:528:DC%2BD3sXivVWlurc%3D 10.1080/0031302021000062424 12701695
-
(2003)
Pathology
, vol.35
, pp. 87-89
-
-
Lloyd, L.1
Klingberg, S.L.2
Kende, M.3
Howell, J.F.4
Clague, A.E.5
-
7
-
-
73649097351
-
IgE myeloma: The first report of Chinese case and a review of the literature
-
J Hou H Jiang H Hu J He 2004 IgE myeloma: the first report of Chinese case and a review of the literature Chin Ger J Clin Oncol 3 189 191
-
(2004)
Chin Ger J Clin Oncol
, vol.3
, pp. 189-191
-
-
Hou, J.1
Jiang, H.2
Hu, H.3
He, J.4
-
8
-
-
73649133986
-
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia
-
1:CAS:528:DC%2BD1MXhs1aqtb3K 10.3109/00313020903434660 20025486
-
W Chiu H Pullon ST Woon P Oei R The R Ameratunga 2010 IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia Pathology 42 82 84 1:CAS:528:DC%2BD1MXhs1aqtb3K 10.3109/00313020903434660 20025486
-
(2010)
Pathology
, vol.42
, pp. 82-84
-
-
Chiu, W.1
Pullon, H.2
Woon, S.T.3
Oei, P.4
The, R.5
Ameratunga, R.6
-
9
-
-
76449090175
-
Plasma cell leukemia producing monoclonal immunoglobulin e
-
10.1007/s12185-009-0407-1 19728026
-
Y Takemura M Ikeda K Kobayashi Y Nakazawa Y Mori T Mitsuishi H Ishigame F Kameko K Fujita R Ichinohasama 2009 Plasma cell leukemia producing monoclonal immunoglobulin E Int J Hematol 90 402 406 10.1007/s12185-009-0407-1 19728026
-
(2009)
Int J Hematol
, vol.90
, pp. 402-406
-
-
Takemura, Y.1
Ikeda, M.2
Kobayashi, K.3
Nakazawa, Y.4
Mori, Y.5
Mitsuishi, T.6
Ishigame, H.7
Kameko, F.8
Fujita, K.9
Ichinohasama, R.10
-
11
-
-
0033054204
-
IgE multiple myeloma
-
1:STN:280:DyaK1M7ls1Wkuw%3D%3D 10048434
-
M Macro I Andre E Comby S Cheze F Chapon JJ Ballet O Reman M Leporrier X Troussard 1999 IgE multiple myeloma Leuk Lymphoma 32 597 603 1:STN:280:DyaK1M7ls1Wkuw%3D%3D 10048434
-
(1999)
Leuk Lymphoma
, vol.32
, pp. 597-603
-
-
MacRo, M.1
Andre, I.2
Comby, E.3
Cheze, S.4
Chapon, F.5
Ballet, J.J.6
Reman, O.7
Leporrier, M.8
Troussard, X.9
-
12
-
-
0016804136
-
A clinical staging system for multiple myeloma Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
-
1:STN:280:DyaE28%2FktFCqtA%3D%3D 10.1002/1097-0142(197509)36:3<842:: AID-CNCR2820360303>3.0.CO;2-U 1182674
-
BG Durie SE Salmon 1975 A clinical staging system for multiple myeloma Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 36 842 854 1:STN:280: DyaE28%2FktFCqtA%3D%3D 10.1002/1097-0142(197509)36:3<842::AID- CNCR2820360303>3.0.CO;2-U 1182674
-
(1975)
Cancer
, vol.36
, pp. 842-854
-
-
Durie, B.G.1
Salmon, S.E.2
-
13
-
-
70350448963
-
How i treat amyloidosis
-
1:CAS:528:DC%2BD1MXhtlShtbjO 10.1182/blood-2009-04-202879 19617578
-
RL Comenzo 2009 How I treat amyloidosis Blood 114 3147 3157 1:CAS:528:DC%2BD1MXhtlShtbjO 10.1182/blood-2009-04-202879 19617578
-
(2009)
Blood
, vol.114
, pp. 3147-3157
-
-
Comenzo, R.L.1
-
14
-
-
0038345324
-
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
-
DOI 10.1046/j.1365-2141.2003.04433.x
-
HJ Lachmann R Gallimore JD Gillmore HD Carr-Smith AR Bradwell MB Pepys PN Hawkins 2003 Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy Br J Haematol 122 78 84 1:CAS:528:DC%2BD3sXmtVGntbw%3D 10.1046/j.1365-2141.2003.04433.x 12823348 (Pubitemid 36819341)
-
(2003)
British Journal of Haematology
, vol.122
, Issue.1
, pp. 78-84
-
-
Lachmann, H.J.1
Gallimore, R.2
Gillmore, J.D.3
Carr-Smith, H.D.4
Bradwell, A.R.5
Pepys, M.B.6
Hawkins, P.N.7
-
15
-
-
33645748052
-
Litzow MR and others Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
-
1:CAS:528:DC%2BD28Xjs1OksLY%3D 10.1182/blood-2005-07-2922 16397135
-
A Dispenzieri MQ Lacy JA Katzmann SV Rajkumar RS Abraham SR Hayman SK Kumar R Clark RA Kyle 2006 Litzow MR and others Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation Blood 107 3378 3383 1:CAS:528:DC%2BD28Xjs1OksLY%3D 10.1182/blood-2005-07-2922 16397135
-
(2006)
Blood
, vol.107
, pp. 3378-3383
-
-
Dispenzieri, A.1
Lacy, M.Q.2
Katzmann, J.A.3
Rajkumar, S.V.4
Abraham, R.S.5
Hayman, S.R.6
Kumar, S.K.7
Clark, R.8
Kyle, R.A.9
-
16
-
-
6944235003
-
Drug therapy: Multiple myeloma
-
DOI 10.1056/NEJMra041875
-
RA Kyle SV Rajkumar 2004 Multiple myeloma N Engl J Med 351 1860 1873 1:CAS:528:DC%2BD2cXptFChtLk%3D 10.1056/NEJMra041875 15509819 (Pubitemid 39426321)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.18
-
-
Kyle, R.A.1
Rajkumar, S.V.2
-
17
-
-
0041989133
-
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review
-
DOI 10.1053/bbmt.2003.50002
-
T Hahn JR Wingard KC Anderson WI Bensinger JR Berenson G Brozeit JR Carver RA Kyle PL McCarthy Jr 2003 The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review Biol Blood Marrow Transpl 9 4 37 10.1053/bbmt.2003.50002 (Pubitemid 41123051)
-
(2003)
Biology of Blood and Marrow Transplantation
, vol.9
, Issue.1
, pp. 4-37
-
-
Hahn, T.1
Wingard, J.R.2
Anderson, K.C.3
Bensinger, W.I.4
Berenson, J.R.5
Brozeit, G.6
Carver, J.R.7
Kyle, R.A.8
McCarthy Jr., P.L.9
-
18
-
-
0028057508
-
IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha
-
1:STN:280:DyaK2c7islCktw%3D%3D 10.1002/ajh.2830450315 8296801
-
N Yamagata C Shimazaki H Goto T Hirata E Ashihara N Oku T Inaba N Fujita M Nakagawa 1994 IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha Am J Hematol 45 262 264 1:STN:280: DyaK2c7islCktw%3D%3D 10.1002/ajh.2830450315 8296801
-
(1994)
Am J Hematol
, vol.45
, pp. 262-264
-
-
Yamagata, N.1
Shimazaki, C.2
Goto, H.3
Hirata, T.4
Ashihara, E.5
Oku, N.6
Inaba, T.7
Fujita, N.8
Nakagawa, M.9
-
19
-
-
20444433230
-
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
-
DOI 10.1056/NEJMoa043445
-
PG Richardson P Sonneveld MW Schuster D Irwin EA Stadtmauer T Facon JL Harousseau D Ben-Yehuda S Lonial 2005 Goldschmidt H and others Bortezomib or high-dose dexamethasone for relapsed multiple myeloma N Engl J Med 352 2487 2498 1:CAS:528:DC%2BD2MXltlaksLc%3D 10.1056/NEJMoa043445 15958804 (Pubitemid 41007864)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.24
, pp. 2487-2498
-
-
Richardson, P.G.1
Sonneveld, P.2
Schuster, M.W.3
Irwin, D.4
Stadtmauer, E.A.5
Facon, T.6
Harousseau, J.-L.7
Ben-Yehuda, D.8
Lonial, S.9
Goldschmidt, H.10
Reece, D.11
San-Miguel, J.F.12
Blade, J.13
Boccadoro, M.14
Cavenagh, J.15
Dalton, W.S.16
Boral, A.L.17
Esseltine, D.L.18
Porter, J.B.19
Schenkein, D.20
Anderson, K.C.21
more..
-
20
-
-
43249097561
-
Thalidomide for treatment of multiple myeloma: 10 years later
-
1:CAS:528:DC%2BD1cXkvFeju7c%3D 10.1182/blood-2007-10-117457 18245666
-
A Palumbo T Facon P Sonneveld J Blade M Offidani F Gay P Moreau A Waage A Spencer H Ludwig, et al. 2008 Thalidomide for treatment of multiple myeloma: 10 years later Blood 111 3968 3977 1:CAS:528:DC%2BD1cXkvFeju7c%3D 10.1182/blood-2007-10-117457 18245666
-
(2008)
Blood
, vol.111
, pp. 3968-3977
-
-
Palumbo, A.1
Facon, T.2
Sonneveld, P.3
Blade, J.4
Offidani, M.5
Gay, F.6
Moreau, P.7
Waage, A.8
Spencer, A.9
Ludwig, H.10
-
21
-
-
36349024733
-
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
-
DOI 10.3324/haematol.11325
-
E Kastritis A Anagnostopoulos M Roussou S Toumanidis C Pamboukas M Migkou A Tassidou I Xilouri S Delibasi E Psimenou, et al. 2007 Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone Haematologica 92 1351 1358 1:CAS:528:DC%2BD2sXht12rurvL 10.3324/haematol.11325 18024372 (Pubitemid 350144152)
-
(2007)
Haematologica
, vol.92
, Issue.10
, pp. 1351-1358
-
-
Kastritis, E.1
Anagnostopoulos, A.2
Roussou, M.3
Toumanidis, S.4
Pamboukas, C.5
Migkou, M.6
Tassidou, A.7
Xilouri, I.8
Delibasi, S.9
Psimenou, E.10
Mellou, S.11
Terpos, E.12
Nanas, J.13
Dimopoulos, M.A.14
-
22
-
-
40849139507
-
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
-
DOI 10.3324/haematol.11627
-
AD Wechalekar HJ Lachmann M Offer PN Hawkins JD Gillmore 2008 Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease Haematologica 93 295 298 1:CAS:528:DC%2BD1cXhsVSiu7zF 10.3324/haematol.11627 18245653 (Pubitemid 351397721)
-
(2008)
Haematologica
, vol.93
, Issue.2
, pp. 295-298
-
-
Wechalekar, A.D.1
Lachmann, H.J.2
Offer, M.3
Hawkins, P.N.4
Gillmore, J.D.5
-
23
-
-
15944395687
-
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)
-
DOI 10.1182/blood-2004-08-3231
-
G Palladini V Perfetti S Perlini L Obici F Lavatelli R Caccialanza R Invernizzi B Comotti G Merlini 2005 The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL) Blood 105 2949 2951 1:CAS:528: DC%2BD2MXivFGmtb0%3D 10.1182/blood-2004-08-3231 15572585 (Pubitemid 40446290)
-
(2005)
Blood
, vol.105
, Issue.7
, pp. 2949-2951
-
-
Palladini, G.1
Perfetti, V.2
Perlini, S.3
Obici, L.4
Lavatelli, F.5
Caccialanza, R.6
Invernizzi, R.7
Comotti, B.8
Merlini, G.9
-
24
-
-
33846263334
-
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
-
DOI 10.1182/blood-2006-07-035352
-
AD Wechalekar HJ Goodman HJ Lachmann M Offer PN Hawkins JD Gillmore 2007 Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis Blood 109 457 464 1:CAS:528: DC%2BD2sXjtVSnur8%3D 10.1182/blood-2006-07-035352 16990593 (Pubitemid 46105938)
-
(2007)
Blood
, vol.109
, Issue.2
, pp. 457-464
-
-
Wechalekar, A.D.1
Goodman, H.J.B.2
Lachmann, H.J.3
Offer, M.4
Hawkins, P.N.5
Gillmore, J.D.6
-
25
-
-
60749115105
-
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide
-
1:CAS:528:DC%2BD1MXitVOlsbc%3D 10.1007/s00277-008-0600-y 18779964
-
G Palladini P Russo F Lavatelli M Nuvolone R Albertini T Bosoni V Perfetti L Obici S Perlini R Moratti, et al. 2009 Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide Ann Hematol 88 347 350 1:CAS:528:DC%2BD1MXitVOlsbc%3D 10.1007/s00277-008-0600-y 18779964
-
(2009)
Ann Hematol
, vol.88
, pp. 347-350
-
-
Palladini, G.1
Russo, P.2
Lavatelli, F.3
Nuvolone, M.4
Albertini, R.5
Bosoni, T.6
Perfetti, V.7
Obici, L.8
Perlini, S.9
Moratti, R.10
-
26
-
-
36949031501
-
Improvement after thalidomide and dexamethasone treatment for advanced cardiac amyloidosis - A case report
-
DOI 10.1253/circj.71.1823
-
JS Choi EN Hwang YH Kim Y Jung HJ Kim SH Nam JI Park 2007 Improvement after thalidomide and dexamethasone treatment for advanced cardiac amyloidosis: a case report Circ J 71 1823 1825 1:CAS:528:DC%2BD2sXhtlGru7vN 10.1253/circj.71.1823 17965510 (Pubitemid 350240111)
-
(2007)
Circulation Journal
, vol.71
, Issue.11
, pp. 1823-1825
-
-
Jin, S.C.1
Eui, N.H.2
Kim, Y.-H.3
Jung, Y.4
Kim, H.-J.5
Nam, S.-H.6
Park, J.-I.7
|